Differences in the binding affinities of ErbB family : heterogeneity in the prediction of resistance mutants
The pressure exerted by drugs targeted to a protein in any therapy inevitably leads to the emergence of drug resistance. One major mechanism of resistance involves the mutation of key residues in the target protein. Drugs that competitively replace a natural substrate are often made ineffective by m...
Main Authors: | Verma, Chandra S., Pereira, Mariana, Fuentes, Gloria |
---|---|
Other Authors: | Salsbury Jr., Freddie |
Format: | Journal Article |
Language: | English |
Published: |
2014
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/95747 http://hdl.handle.net/10220/18380 |
Similar Items
-
Computational modeling of ErbB kinase oligomeric state.
by: Lim, Sing Mei.
Published: (2010) -
Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
by: Kranthi Kumar Chougoni, et al.
Published: (2023-11-01) -
Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
by: Sho Ueno, et al.
Published: (2020-06-01) -
Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer
by: Emilia Rabia, et al.
Published: (2023-04-01) -
The role of protease activity in ErbB biology.
by: Blobel, C, et al.
Published: (2009)